Connection

Franco Locatelli to Child, Preschool

Back to Details
This is a "connection" page, showing publications Franco Locatelli has written about Child, Preschool.
Franco Locatelli
Connection Strength
0.735
Child, Preschool
  1. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. HLA. 2020 11; 96(5):610-614.
    View in: PubMed
    Score: 0.039
  2. Role of interferon-? in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019 11; 104(11):2314-2323.
    View in: PubMed
    Score: 0.035
  3. Unrelated donor vs HLA-haploidentical a/ß T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. 2018 12 13; 132(24):2594-2607.
    View in: PubMed
    Score: 0.034
  4. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018 Oct; 5(10):e450-e461.
    View in: PubMed
    Score: 0.034
  5. Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia. Br J Haematol. 2019 04; 185(2):360-363.
    View in: PubMed
    Score: 0.033
  6. How I treat myelodysplastic syndromes of childhood. Blood. 2018 03 29; 131(13):1406-1414.
    View in: PubMed
    Score: 0.032
  7. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy. Biol Blood Marrow Transplant. 2018 06; 24(6):1223-1231.
    View in: PubMed
    Score: 0.032
  8. Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia. Expert Rev Hematol. 2018 02; 11(2):129-143.
    View in: PubMed
    Score: 0.032
  9. Protocol II vs protocol III given twice during reinduction therapy in children with medium-risk ALL. Blood. 2017 11 09; 130(19):2146-2149.
    View in: PubMed
    Score: 0.031
  10. Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1126-1136.
    View in: PubMed
    Score: 0.031
  11. Outcome of children with acute leukemia given HLA-haploidentical HSCT after aß T-cell and B-cell depletion. Blood. 2017 08 03; 130(5):677-685.
    View in: PubMed
    Score: 0.031
  12. A New Enzyme-Linked Immunosorbent Assay for a Total Anti-T Lymphocyte Globulin Determination: Development, Analytical Validation, and Clinical Applications. Ther Drug Monit. 2017 06; 39(3):282-289.
    View in: PubMed
    Score: 0.031
  13. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. Br J Haematol. 2017 02; 176(4):629-636.
    View in: PubMed
    Score: 0.030
  14. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005 Jan 01; 105(1):410-9.
    View in: PubMed
    Score: 0.013
  15. Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network. Front Immunol. 2019; 10:1908.
    View in: PubMed
    Score: 0.009
  16. Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019; 10:316.
    View in: PubMed
    Score: 0.009
  17. Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency. J Allergy Clin Immunol Pract. 2019 Jul - Aug; 7(6):1970-1985.e4.
    View in: PubMed
    Score: 0.009
  18. Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. Eur J Cancer. 2019 03; 110:86-97.
    View in: PubMed
    Score: 0.009
  19. Risk factors affecting outcome of unrelated cord blood transplantation for children with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2019 02; 184(3):397-404.
    View in: PubMed
    Score: 0.009
  20. Correspondence: Osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort study of the Italian Association of Pediatric Haemato-Oncology (AIEOP). Blood Cancer J. 2018 11 15; 8(12):115.
    View in: PubMed
    Score: 0.009
  21. Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience. Acta Haematol. 2018; 140(2):105-111.
    View in: PubMed
    Score: 0.008
  22. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group. Blood. 2018 10 11; 132(15):1584-1592.
    View in: PubMed
    Score: 0.008
  23. Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia. Blood Cancer J. 2018 08 22; 8(9):80.
    View in: PubMed
    Score: 0.008
  24. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL. Blood. 2018 07 26; 132(4):405-412.
    View in: PubMed
    Score: 0.008
  25. Late Development of FceR?neg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients. Front Immunol. 2018; 9:1050.
    View in: PubMed
    Score: 0.008
  26. Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma. Cancer Res. 2018 06 15; 78(12):3337-3349.
    View in: PubMed
    Score: 0.008
  27. Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy. Leuk Lymphoma. 2018 11; 59(11):2612-2621.
    View in: PubMed
    Score: 0.008
  28. Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. Leukemia. 2018 05; 32(5):1124-1134.
    View in: PubMed
    Score: 0.008
  29. Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia. Br J Haematol. 2018 03; 180(5):680-693.
    View in: PubMed
    Score: 0.008
  30. Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party. Biol Blood Marrow Transplant. 2018 04; 24(4):799-805.
    View in: PubMed
    Score: 0.008
  31. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017 12 19; 8(1):2126.
    View in: PubMed
    Score: 0.008
  32. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol. 2018 03; 141(3):1036-1049.e5.
    View in: PubMed
    Score: 0.008
  33. Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000). J Clin Oncol. 2018 01 20; 36(3):244-253.
    View in: PubMed
    Score: 0.008
  34. High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study. Br J Haematol. 2017 12; 179(5):772-780.
    View in: PubMed
    Score: 0.008
  35. A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia. Br J Haematol. 2018 10; 183(2):298-301.
    View in: PubMed
    Score: 0.008
  36. Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia. J Cell Physiol. 2018 Mar; 233(3):1796-1811.
    View in: PubMed
    Score: 0.008
  37. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. Sci Rep. 2017 08 15; 7(1):8153.
    View in: PubMed
    Score: 0.008
  38. Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2017 Nov; 23(11):1939-1948.
    View in: PubMed
    Score: 0.008
  39. Whole Genome MBD-seq reveals different CpG methylation patterns in Azacytidine-treated Juvenile Myelomonocytic Leukaemia (JMML) patients. Br J Haematol. 2018 09; 182(6):909-912.
    View in: PubMed
    Score: 0.008
  40. Open issues in Mucopolysaccharidosis type I-Hurler. Orphanet J Rare Dis. 2017 06 15; 12(1):112.
    View in: PubMed
    Score: 0.008
  41. Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.008
  42. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Ann Hematol. 2017 Sep; 96(9):1449-1456.
    View in: PubMed
    Score: 0.008
  43. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients. Pediatr Nephrol. 2017 08; 32(8):1433-1442.
    View in: PubMed
    Score: 0.008
  44. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. Clin Cancer Res. 2017 Aug 01; 23(15):4462-4472.
    View in: PubMed
    Score: 0.008
  45. Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol. Br J Haematol. 2017 04; 177(1):116-126.
    View in: PubMed
    Score: 0.008
  46. An early-biomarker algorithm predicts lethal graft-versus-host disease and survival. JCI Insight. 2017 02 09; 2(3):e89798.
    View in: PubMed
    Score: 0.008
  47. Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group. Oncotarget. 2016 May 17; 7(20):28914-9.
    View in: PubMed
    Score: 0.007
  48. The prognostic value of biological markers in paediatric Hodgkin lymphoma. Eur J Cancer. 2016 Jan; 52:33-40.
    View in: PubMed
    Score: 0.007
  49. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood. 2015 Apr 02; 125(14):2311-3.
    View in: PubMed
    Score: 0.007
  50. Haematopoietic stem cell transplantation for Diamond Blackfan anaemia: a report from the Italian Association of Paediatric Haematology and Oncology Registry. Br J Haematol. 2014 Jun; 165(5):673-81.
    View in: PubMed
    Score: 0.006
  51. Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host. Clin Immunol. 2010 Aug; 136(2):269-81.
    View in: PubMed
    Score: 0.005
  52. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Haematologica. 2007 Sep; 92(9):1186-93.
    View in: PubMed
    Score: 0.004
  53. A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol. 2002 Sep; 118(3):741-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.